Literature DB >> 16511611

Fabry disease.

Mark Levin1.   

Abstract

Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure. Preclinical and clinical studies demonstrate effectiveness of enzyme infusion in controlling and preventing these manifestations of the disease. Copyright 2006 Prous Science

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511611     DOI: 10.1358/dot.2006.42.1.957357

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  1 in total

1.  Mutation patterns in human alpha-galactosidase A.

Authors:  Shaomin Yan; Guang Wu
Journal:  Mol Divers       Date:  2009-05-26       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.